Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

Clinical trial NCT00492466 · COMPLETED

Trial details

NCT number: NCT00492466
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2003-03-01
Primary completion: 2006-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.